| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:5000 |
| FC | 1:50-1:200 |
BIRC3, also known as cellular inhibitor of apoptosis 2 (c-IAP2), plays a critical role in regulating programmed cell death and NF-κB signaling pathways. As a RING-type E3 ubiquitin ligase, BIRC3 modulates cell survival decisions by inhibiting caspases and facilitating ubiquitin-dependent signaling downstream of TNF receptor complexes. Its dysregulation has been implicated in various malignancies and inflammatory conditions, making it a significant target for researchers investigating apoptotic mechanisms, cancer biology, and immune signaling networks.
This recombinant rabbit monoclonal antibody (clone 7E9) offers the reproducibility and consistency that demanding experimental workflows require. Generated against a synthetic peptide derived from human BIRC3, the antibody is produced using recombinant technology, ensuring sequence-defined specificity and eliminating the lot-to-lot variability that can compromise longitudinal studies. Affinity chromatography purification delivers a reagent suitable for quantitative applications where signal reliability matters.
Validation studies confirm robust performance in flow cytometry applications, with recommended dilutions of 1:50 to 1:200. Flow cytometric analysis using Raji cells demonstrated clear positive signal separation from isotype controls, with intracellular staining performed following fixation and permeabilization. Western blot analysis in Raji whole cell lysate detected a band at approximately 72 kDa, slightly higher than the predicted 68 kDa molecular weight—a shift commonly attributable to post-translational modifications such as ubiquitination or phosphorylation events consistent with BIRC3's regulatory functions.
This antibody serves researchers studying apoptosis regulation, NF-κB pathway dynamics, and ubiquitin-mediated signaling in human samples, providing a reliable tool for both cell-based assays and protein detection applications.
Email: support@cusabio.com
Distributors Worldwide